Cargando…
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
Cancer patients receiving anthracycline-based chemotherapy are at risk to develop life-threatening chronic cardiotoxicity with the pathophysiological mechanism of action not fully understood. Besides the most common hypothesis that anthracycline-induced congestive heart failure (CHF) is mainly cause...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386353/ https://www.ncbi.nlm.nih.gov/pubmed/28102848 http://dx.doi.org/10.1038/cddis.2016.418 |